speb/financial-data huggingface dataset:
CRAQ balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 3668.00
CRAQ income_statement (quarterly, 2025-09-30) — EBIT: -128629.00
CRAQ income_statement (quarterly, 2025-09-30) — EBITDA: -128629.00
CRAQ cash_flow (quarterly, 2025-09-30) — End Cash Position: 1154388.00
CRAQ cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 0.00
CRAQ cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -237791.00
CRAQ cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -2456512.00
CRAQ income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 2456512.00
CRAQ income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 128629.00
CRAQ income_statement (quarterly, 2025-09-30) — Gross Profit: 0.00
CRAQ income_statement (quarterly, 2025-09-30) — Interest Income: 11571.00
CRAQ income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 11571.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Invested Capital: 225333136.00
CRAQ cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 0.00
CRAQ cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CRAQ cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CRAQ income_statement (quarterly, 2025-09-30) — Net Income: 2339454.00
CRAQ income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 2339454.00
CRAQ income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 2339454.00
CRAQ income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 2339454.00
CRAQ income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 2339454.00
CRAQ cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 2339454.00
CRAQ income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 2339454.00
CRAQ income_statement (quarterly, 2025-09-30) — Net Interest Income: 11571.00
CRAQ income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 11571.00
CRAQ cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
CRAQ cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 0.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 225332835.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 63325.00
CRAQ income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -2585141.00
CRAQ income_statement (quarterly, 2025-09-30) — Normalized Income: 398809.52
CRAQ cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -237791.00
CRAQ cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -2456512.00
CRAQ income_statement (quarterly, 2025-09-30) — Operating Income: -128629.00
CRAQ income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 31325900.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 301.00
CRAQ income_statement (quarterly, 2025-09-30) — Other Gand A: 128629.00
CRAQ income_statement (quarterly, 2025-09-30) — Other Income Expense: 2456512.00
CRAQ cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 0.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 233324664.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Payables: 58257.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 133257.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 124016.00
CRAQ income_statement (quarterly, 2025-09-30) — Pretax Income: 2339454.00
CRAQ income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 0.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -7992662.00
CRAQ income_statement (quarterly, 2025-09-30) — Selling General And Administration: 128629.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Share Issued: 31325900.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 225332835.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 225332835.00
CRAQ income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 515867.52
CRAQ income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CRAQ balance_sheet (quarterly, 2025-09-30) — Total Assets: 234666393.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 225332835.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Total Debt: 301.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 225332835.00
CRAQ income_statement (quarterly, 2025-09-30) — Total Expenses: 128629.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 9333558.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 233387989.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 9200000.00
CRAQ income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -128629.00
CRAQ income_statement (quarterly, 2025-09-30) — Total Unusual Items: 2456512.00
CRAQ income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 2456512.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 9200000.00
CRAQ balance_sheet (quarterly, 2025-09-30) — Working Capital: 1144846.00
CRAQ income_statement (annual, 2025-12-31) — +Operating Expense: 467994.00
CRAQ income_statement (quarterly, 2025-12-31) — +Operating Expense: 160164.00
CRAQ income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
CRAQ income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
CRAQ balance_sheet (annual, 2025-12-31) — Accounts Payable: 74547.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 74547.00
CRAQ income_statement (annual, 2025-12-31) — Basic Average Shares: 21709226.00
CRAQ income_statement (annual, 2025-12-31) — Basic EPS: 0.23
CRAQ cash_flow (annual, 2025-12-31) — Beginning Cash Position: 0.00
CRAQ cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1154388.00
CRAQ balance_sheet (annual, 2025-12-31) — Capital Stock: 235634398.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Capital Stock: 235634398.00
CRAQ balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1096942.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1096942.00
CRAQ balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1096942.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1096942.00
CRAQ balance_sheet (annual, 2025-12-31) — Cash Financial: 1096942.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Cash Financial: 1096942.00
CRAQ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 231543427.00
CRAQ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 0.00
CRAQ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -230000000.00
CRAQ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
CRAQ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -446485.00
CRAQ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -57446.00
CRAQ cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 74547.00
CRAQ cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 19958.00
CRAQ cash_flow (annual, 2025-12-31) — Change In Payable: 29694.00
CRAQ cash_flow (quarterly, 2025-12-31) — Change In Payable: 26026.00
CRAQ cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 104241.00
CRAQ cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 45984.00
CRAQ cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -140630.00
CRAQ cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 46711.00
CRAQ cash_flow (annual, 2025-12-31) — Change In Working Capital: -36389.00
CRAQ cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 92695.00
CRAQ cash_flow (annual, 2025-12-31) — Changes In Cash: 1096942.00
CRAQ cash_flow (quarterly, 2025-12-31) — Changes In Cash: -57446.00
CRAQ balance_sheet (annual, 2025-12-31) — Common Stock: 235634398.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Common Stock: 235634398.00
CRAQ balance_sheet (annual, 2025-12-31) — Common Stock Equity: 227491595.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 227491595.00
CRAQ cash_flow (annual, 2025-12-31) — Common Stock Issuance: 232025000.00
CRAQ cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CRAQ income_statement (annual, 2025-12-31) — Cost Of Revenue: 132300.00
CRAQ income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 0.00
CRAQ balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 75000.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 75000.00
CRAQ balance_sheet (annual, 2025-12-31) — Current Assets: 1199038.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Current Assets: 1199038.00
CRAQ balance_sheet (annual, 2025-12-31) — Current Debt: 301.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Current Debt: 301.00
CRAQ balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 301.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 301.00
CRAQ balance_sheet (annual, 2025-12-31) — Current Liabilities: 179542.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 179542.00
CRAQ income_statement (annual, 2025-12-31) — Diluted Average Shares: 21865199.00
CRAQ income_statement (annual, 2025-12-31) — Diluted EPS: 0.23
CRAQ income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 5054949.00
CRAQ income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2158760.00
CRAQ balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 29694.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 29694.00
CRAQ income_statement (annual, 2025-12-31) — EBIT: -600294.00
CRAQ income_statement (quarterly, 2025-12-31) — EBIT: -160164.00
CRAQ income_statement (annual, 2025-12-31) — EBITDA: -600294.00
CRAQ income_statement (quarterly, 2025-12-31) — EBITDA: -160164.00
CRAQ cash_flow (annual, 2025-12-31) — End Cash Position: 1096942.00
CRAQ cash_flow (quarterly, 2025-12-31) — End Cash Position: 1096942.00
CRAQ cash_flow (annual, 2025-12-31) — Financing Cash Flow: 231543427.00
CRAQ cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 0.00
CRAQ cash_flow (annual, 2025-12-31) — Free Cash Flow: -446485.00
CRAQ cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -57446.00
CRAQ cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -5633565.00
CRAQ cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -2308901.00
CRAQ income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 5633565.00
CRAQ income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 2308901.00
CRAQ income_statement (annual, 2025-12-31) — General And Administrative Expense: 467994.00
CRAQ income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 160164.00
CRAQ income_statement (annual, 2025-12-31) — Gross Profit: -132300.00
CRAQ income_statement (quarterly, 2025-12-31) — Gross Profit: 0.00
CRAQ income_statement (annual, 2025-12-31) — Interest Income: 26678.00
CRAQ income_statement (quarterly, 2025-12-31) — Interest Income: 10023.00
CRAQ income_statement (annual, 2025-12-31) — Interest Income Non Operating: 26678.00
CRAQ income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 10023.00
CRAQ balance_sheet (annual, 2025-12-31) — Invested Capital: 227491896.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Invested Capital: 227491896.00
CRAQ cash_flow (annual, 2025-12-31) — Investing Cash Flow: -230000000.00
CRAQ cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 0.00
CRAQ cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 232025000.00
CRAQ cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
CRAQ cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 232025000.00
CRAQ cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
CRAQ income_statement (annual, 2025-12-31) — Net Income: 5054949.00
CRAQ income_statement (quarterly, 2025-12-31) — Net Income: 2158760.00
CRAQ income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 5054949.00
CRAQ income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2158760.00
CRAQ income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 5054949.00
CRAQ income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2158760.00
CRAQ income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 5054949.00
CRAQ income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2158760.00
CRAQ income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 5054949.00
CRAQ income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2158760.00
CRAQ cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 5054949.00
CRAQ cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 2158760.00
CRAQ income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 5054949.00
CRAQ income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2158760.00
CRAQ income_statement (annual, 2025-12-31) — Net Interest Income: 21678.00
CRAQ income_statement (quarterly, 2025-12-31) — Net Interest Income: 10023.00
CRAQ income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 21678.00
CRAQ income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 10023.00
CRAQ cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -481573.00
CRAQ cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
CRAQ cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -230000000.00
CRAQ cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
CRAQ balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 227491595.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 227491595.00
CRAQ balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 38534.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 38534.00
CRAQ income_statement (annual, 2025-12-31) — Normalized EBITDA: -6233859.00
CRAQ income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -2469065.00
CRAQ income_statement (annual, 2025-12-31) — Normalized Income: 604432.65
CRAQ income_statement (quarterly, 2025-12-31) — Normalized Income: 334728.21
CRAQ cash_flow (annual, 2025-12-31) — Operating Cash Flow: -446485.00
CRAQ cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -57446.00
CRAQ cash_flow (annual, 2025-12-31) — Operating Gains Losses: -5633565.00
CRAQ cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -2308901.00
CRAQ income_statement (annual, 2025-12-31) — Operating Income: -600294.00
CRAQ income_statement (quarterly, 2025-12-31) — Operating Income: -160164.00
CRAQ income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
CRAQ income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
CRAQ balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 31325900.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 31325900.00
CRAQ balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 301.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 301.00
CRAQ income_statement (annual, 2025-12-31) — Other Gand A: 467994.00
CRAQ income_statement (quarterly, 2025-12-31) — Other Gand A: 160164.00
CRAQ income_statement (annual, 2025-12-31) — Other Income Expense: 5633565.00
CRAQ income_statement (quarterly, 2025-12-31) — Other Income Expense: 2308901.00
CRAQ cash_flow (annual, 2025-12-31) — Other Non Cash Items: 168520.00
CRAQ cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 0.00
CRAQ balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 235633565.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 235633565.00
CRAQ balance_sheet (annual, 2025-12-31) — Payables: 104241.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Payables: 104241.00
CRAQ balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 179241.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 179241.00
CRAQ balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CRAQ balance_sheet (annual, 2025-12-31) — Prepaid Assets: 102096.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 102096.00
CRAQ income_statement (annual, 2025-12-31) — Pretax Income: 5054949.00
CRAQ income_statement (quarterly, 2025-12-31) — Pretax Income: 2158760.00
CRAQ income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 132300.00
CRAQ income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 0.00
CRAQ balance_sheet (annual, 2025-12-31) — Retained Earnings: -8142803.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -8142803.00
CRAQ income_statement (annual, 2025-12-31) — Selling General And Administration: 467994.00
CRAQ income_statement (quarterly, 2025-12-31) — Selling General And Administration: 160164.00
CRAQ balance_sheet (annual, 2025-12-31) — Share Issued: 31325900.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Share Issued: 31325900.00
CRAQ balance_sheet (annual, 2025-12-31) — Stockholders Equity: 227491595.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 227491595.00
CRAQ balance_sheet (annual, 2025-12-31) — Tangible Book Value: 227491595.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 227491595.00
CRAQ income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 1183048.65
CRAQ income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 484869.21
CRAQ income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
CRAQ income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CRAQ balance_sheet (annual, 2025-12-31) — Total Assets: 236871137.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Total Assets: 236871137.00
CRAQ balance_sheet (annual, 2025-12-31) — Total Capitalization: 227491595.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 227491595.00
CRAQ balance_sheet (annual, 2025-12-31) — Total Debt: 301.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Total Debt: 301.00
CRAQ balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 227491595.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 227491595.00
CRAQ income_statement (annual, 2025-12-31) — Total Expenses: 600294.00
CRAQ income_statement (quarterly, 2025-12-31) — Total Expenses: 160164.00
CRAQ balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 9379542.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 9379542.00
CRAQ balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 235672099.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 235672099.00
CRAQ balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 9200000.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 9200000.00
CRAQ income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -467994.00
CRAQ income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -160164.00
CRAQ income_statement (annual, 2025-12-31) — Total Other Finance Cost: 5000.00
CRAQ income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 0.00
CRAQ income_statement (annual, 2025-12-31) — Total Unusual Items: 5633565.00
CRAQ income_statement (quarterly, 2025-12-31) — Total Unusual Items: 2308901.00
CRAQ income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 5633565.00
CRAQ income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 2308901.00
CRAQ balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 9200000.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 9200000.00
CRAQ balance_sheet (annual, 2025-12-31) — Working Capital: 1019496.00
CRAQ balance_sheet (quarterly, 2025-12-31) — Working Capital: 1019496.00
CRAQ income_statement (quarterly, 2026-03-31) — +Operating Expense: 132112.00
CRAQ income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 106416.00
CRAQ income_statement (quarterly, 2026-03-31) — Basic Average Shares: 31325900.00
CRAQ income_statement (quarterly, 2026-03-31) — Basic EPS: 0.06
CRAQ cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1096942.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Capital Stock: 237676023.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 962299.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 962299.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Cash Financial: 962299.00
CRAQ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 0.00
CRAQ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -134643.00
CRAQ cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 31869.00
CRAQ cash_flow (quarterly, 2026-03-31) — Change In Payable: -4200.00
CRAQ cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 27669.00
CRAQ cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -38309.00
CRAQ cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -10640.00
CRAQ cash_flow (quarterly, 2026-03-31) — Changes In Cash: -134643.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Common Stock: 237676023.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 229409217.00
CRAQ cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 75000.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Current Assets: 1131156.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Current Debt: 301.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 301.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 211411.00
CRAQ income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 31325900.00
CRAQ income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.06
CRAQ income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1917622.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 4200.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 29694.00
CRAQ income_statement (quarterly, 2026-03-31) — EBIT: -132112.00
CRAQ income_statement (quarterly, 2026-03-31) — EBITDA: -132112.00
CRAQ cash_flow (quarterly, 2026-03-31) — End Cash Position: 962299.00
CRAQ cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 0.00
CRAQ cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -134643.00
CRAQ cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -2041625.00
CRAQ income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 2041625.00
CRAQ income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 132112.00
CRAQ income_statement (quarterly, 2026-03-31) — Interest Income: 8109.00
CRAQ income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 8109.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Invested Capital: 229409518.00
CRAQ cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
CRAQ cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
CRAQ income_statement (quarterly, 2026-03-31) — Net Income: 1917622.00
CRAQ income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1917622.00
CRAQ income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1917622.00
CRAQ income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1917622.00
CRAQ income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1917622.00
CRAQ cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1917622.00
CRAQ income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1917622.00
CRAQ income_statement (quarterly, 2026-03-31) — Net Interest Income: 8109.00
CRAQ income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 8109.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 229409217.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 14282.00
CRAQ income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -2173737.00
CRAQ income_statement (quarterly, 2026-03-31) — Normalized Income: 692647.00
CRAQ cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -134643.00
CRAQ cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -2041625.00
CRAQ income_statement (quarterly, 2026-03-31) — Operating Income: -132112.00
CRAQ income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 31325900.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 301.00
CRAQ income_statement (quarterly, 2026-03-31) — Other Gand A: 132112.00
CRAQ income_statement (quarterly, 2026-03-31) — Other Income Expense: 2041625.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 237675190.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Payables: 136110.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 211110.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 164657.00
CRAQ income_statement (quarterly, 2026-03-31) — Pretax Income: 1917622.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Receivables: 4200.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -8266806.00
CRAQ income_statement (quarterly, 2026-03-31) — Selling General And Administration: 132112.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Share Issued: 31325900.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 229409217.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 229409217.00
CRAQ income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 816650.00
CRAQ income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CRAQ balance_sheet (quarterly, 2026-03-31) — Total Assets: 238820628.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 229409217.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Total Debt: 301.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 229409217.00
CRAQ income_statement (quarterly, 2026-03-31) — Total Expenses: 132112.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 9411411.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 237689472.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 9200000.00
CRAQ income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -132112.00
CRAQ income_statement (quarterly, 2026-03-31) — Total Unusual Items: 2041625.00
CRAQ income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 2041625.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 9200000.00
CRAQ balance_sheet (quarterly, 2026-03-31) — Working Capital: 919745.00
CRAV.PA cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -635000.00
CRAV.PA balance_sheet (annual, 2021-12-31) — Held To Maturity Securities: 0.00
CRAV.PA balance_sheet (annual, 2021-12-31) — Investments In Other Ventures Under Equity Method: 0.00
CRAV.PA balance_sheet (annual, 2021-12-31) — Long Term Equity Investment: 0.00
CRAV.PA cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: -7519000.00
CRAV.PA income_statement (annual, 2022-12-31) — +Operating Expense: 323295000.00
CRAV.PA income_statement (annual, 2022-12-31) — +Total Revenue: 493583000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -198346000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 2503722000.00
CRAV.PA income_statement (annual, 2022-12-31) — Basic Average Shares: 7386586.00
CRAV.PA income_statement (annual, 2022-12-31) — Basic EPS: 17.99
CRAV.PA cash_flow (annual, 2022-12-31) — Beginning Cash Position: 2559873000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Capital Expenditure: -28720000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Capital Stock: 451581000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 90537000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 105457000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Cash Financial: 61098000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 1563271000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Change In Working Capital: -309877000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Changes In Cash: -132071000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Common Stock: 451581000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Common Stock Equity: 3547464000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Depreciation: 20091000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 20091000.00
CRAV.PA income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 20688000.00
CRAV.PA income_statement (annual, 2022-12-31) — Depreciation Income Statement: 20688000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 35981000.00
CRAV.PA income_statement (annual, 2022-12-31) — Diluted Average Shares: 7386586.00
CRAV.PA income_statement (annual, 2022-12-31) — Diluted EPS: 17.99
CRAV.PA income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 132902000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 0.00
CRAV.PA cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 0.00
CRAV.PA cash_flow (annual, 2022-12-31) — End Cash Position: 2427802000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 242540000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Financing Cash Flow: 17398000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Free Cash Flow: -139742000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -515000.00
CRAV.PA income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -2380000.00
CRAV.PA income_statement (annual, 2022-12-31) — General And Administrative Expense: 90414000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Goodwill: 0.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 4519000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Gross PPE: 412081000.00
CRAV.PA income_statement (annual, 2022-12-31) — Interest Expense: 226792000.00
CRAV.PA income_statement (annual, 2022-12-31) — Interest Income: 484710000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Invested Capital: 4143883000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Investing Cash Flow: -38447000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Investment Properties: 10423000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 2846042000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Investments And Advances: 2846042000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 0.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 601156000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 0.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Minority Interest: 0.00
CRAV.PA income_statement (annual, 2022-12-31) — Minority Interests: 0.00
CRAV.PA cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -9727000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -110000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Net Debt: 505882000.00
CRAV.PA income_statement (annual, 2022-12-31) — Net Income: 132902000.00
CRAV.PA income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 132902000.00
CRAV.PA income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 132902000.00
CRAV.PA income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 0.00
CRAV.PA income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 132902000.00
CRAV.PA income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 132902000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 161302000.00
CRAV.PA income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 132902000.00
CRAV.PA income_statement (annual, 2022-12-31) — Net Interest Income: 257918000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -9727000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 17508000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Net PPE: 213735000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -28720000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 3542945000.00
CRAV.PA income_statement (annual, 2022-12-31) — Normalized Income: 132478515.40
CRAV.PA cash_flow (annual, 2022-12-31) — Operating Cash Flow: -111022000.00
CRAV.PA income_statement (annual, 2022-12-31) — Operating Revenue: 493583000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 7386586.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Other Equity Interest: 561086000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 4519000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Other Non Cash Items: 45394000.00
CRAV.PA income_statement (annual, 2022-12-31) — Other Operating Expenses: 25935000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Other Payable: 1446374000.00
CRAV.PA income_statement (annual, 2022-12-31) — Other Special Charges: -515000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Payables: 1451055000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Prepaid Assets: 3105000.00
CRAV.PA income_statement (annual, 2022-12-31) — Pretax Income: 161302000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 8138000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Receivables: 326768000.00
CRAV.PA income_statement (annual, 2022-12-31) — Reconciled Depreciation: 20091000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Retained Earnings: 132902000.00
CRAV.PA income_statement (annual, 2022-12-31) — Selling General And Administration: 90414000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Share Issued: 7392865.00
CRAV.PA income_statement (annual, 2022-12-31) — Special Income Charges: 514000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Stockholders Equity: 3547464000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Tangible Book Value: 3542945000.00
CRAV.PA income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 90515.40
CRAV.PA income_statement (annual, 2022-12-31) — Tax Provision: 28400000.00
CRAV.PA income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.18
CRAV.PA balance_sheet (annual, 2022-12-31) — Taxes Receivable: 66050000.00
CRAV.PA cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -35555000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Total Assets: 31524062000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Total Capitalization: 4143883000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Total Debt: 601156000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 3547464000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 27976598000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Total Tax Payable: 4681000.00
CRAV.PA income_statement (annual, 2022-12-31) — Total Unusual Items: 514000.00
CRAV.PA income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 514000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Trading Securities: 25229000.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 6279.00
CRAV.PA balance_sheet (annual, 2022-12-31) — Treasury Stock: 605000.00
CRAV.PA income_statement (annual, 2022-12-31) — Write Off: 1000.00
CRAV.PA income_statement (annual, 2023-12-31) — +Operating Expense: 324452000.00
CRAV.PA income_statement (annual, 2023-12-31) — +Total Revenue: 413227000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -203937000.00
CRAV.PA income_statement (annual, 2023-12-31) — Amortization: 32000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 2635021000.00
CRAV.PA income_statement (annual, 2023-12-31) — Basic Average Shares: 7385542.00
CRAV.PA income_statement (annual, 2023-12-31) — Basic EPS: 11.70
CRAV.PA cash_flow (annual, 2023-12-31) — Beginning Cash Position: 2427802000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Capital Expenditure: -42941000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Capital Stock: 439543000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 170564000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 418966000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Cash Financial: 54763000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -907219000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Change In Working Capital: -974614000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Changes In Cash: -981724000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Common Stock: 439543000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Common Stock Equity: 3744856000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Depreciation: 20836000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 20836000.00
CRAV.PA income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 21016000.00
CRAV.PA income_statement (annual, 2023-12-31) — Depreciation Income Statement: 20984000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 172997000.00
CRAV.PA income_statement (annual, 2023-12-31) — Diluted Average Shares: 7385542.00
CRAV.PA income_statement (annual, 2023-12-31) — Diluted EPS: 11.70
CRAV.PA income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 86407000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Dividend Received Cfo: 0.00
CRAV.PA cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 0.00
CRAV.PA cash_flow (annual, 2023-12-31) — End Cash Position: 1446078000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 262623000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Financing Cash Flow: -70764000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Free Cash Flow: -903227000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -472000.00
CRAV.PA income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 9061000.00
CRAV.PA income_statement (annual, 2023-12-31) — General And Administrative Expense: 89547000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Goodwill: 0.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 4735000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Gross PPE: 441432000.00
CRAV.PA income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
CRAV.PA income_statement (annual, 2023-12-31) — Interest Expense: 860736000.00
CRAV.PA income_statement (annual, 2023-12-31) — Interest Income: 1034992000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Invested Capital: 4175838000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Investing Cash Flow: -50674000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Investment Properties: 9969000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 3139094000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Investments And Advances: 3139094000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 436987000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Minority Interest: 0.00
CRAV.PA income_statement (annual, 2023-12-31) — Minority Interests: 0.00
CRAV.PA cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -7733000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -31921000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Net Debt: 260418000.00
CRAV.PA income_statement (annual, 2023-12-31) — Net Income: 86407000.00
CRAV.PA income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 86407000.00
CRAV.PA income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 86407000.00
CRAV.PA income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: 0.00
CRAV.PA income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 86407000.00
CRAV.PA income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 86407000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 93237000.00
CRAV.PA income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 86407000.00
CRAV.PA income_statement (annual, 2023-12-31) — Net Interest Income: 174256000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -7733000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -38843000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Net PPE: 237495000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -42941000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 3740121000.00
CRAV.PA income_statement (annual, 2023-12-31) — Normalized Income: 85897315.00
CRAV.PA cash_flow (annual, 2023-12-31) — Operating Cash Flow: -860286000.00
CRAV.PA income_statement (annual, 2023-12-31) — Operating Revenue: 413227000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 7385542.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Other Equity Interest: 703556000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 4735000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Other Non Cash Items: -4685000.00
CRAV.PA income_statement (annual, 2023-12-31) — Other Operating Expenses: 20628000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Other Payable: 762092000.00
CRAV.PA income_statement (annual, 2023-12-31) — Other Special Charges: -543000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Payables: 766902000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Prepaid Assets: 3534000.00
CRAV.PA income_statement (annual, 2023-12-31) — Pretax Income: 93237000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 19273000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Receivables: 323588000.00
CRAV.PA income_statement (annual, 2023-12-31) — Reconciled Depreciation: 20836000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Retained Earnings: 86407000.00
CRAV.PA income_statement (annual, 2023-12-31) — Selling General And Administration: 89547000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Share Issued: 7391529.00
CRAV.PA income_statement (annual, 2023-12-31) — Special Income Charges: 550000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Stockholders Equity: 3744856000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Tangible Book Value: 3740121000.00
CRAV.PA income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 40315.00
CRAV.PA income_statement (annual, 2023-12-31) — Tax Provision: 6830000.00
CRAV.PA income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.07
CRAV.PA balance_sheet (annual, 2023-12-31) — Taxes Receivable: 69183000.00
CRAV.PA cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -13861000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Total Assets: 31159245000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Total Capitalization: 4175838000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Total Debt: 436987000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 3744856000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 27414389000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Total Tax Payable: 4810000.00
CRAV.PA income_statement (annual, 2023-12-31) — Total Unusual Items: 550000.00
CRAV.PA income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 550000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Trading Securities: 14323000.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 5987.00
CRAV.PA balance_sheet (annual, 2023-12-31) — Treasury Stock: 548000.00
CRAV.PA income_statement (annual, 2023-12-31) — Write Off: -7000.00
CRAV.PA income_statement (annual, 2024-12-31) — +Operating Expense: 330862000.00
CRAV.PA income_statement (annual, 2024-12-31) — +Total Revenue: 425392000.00
CRAV.PA balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -220316000.00
CRAV.PA balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -220316000.00
CRAV.PA income_statement (annual, 2024-12-31) — Amortization: 7000.00
CRAV.PA balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 3086064000.00
CRAV.PA balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 3086064000.00
CRAV.PA income_statement (annual, 2024-12-31) — Basic Average Shares: 7382465.00
CRAV.PA income_statement (annual, 2024-12-31) — Basic EPS: 11.59
CRAV.PA cash_flow (annual, 2024-12-31) — Beginning Cash Position: 1446078000.00
CRAV.PA cash_flow (annual, 2024-12-31) — Capital Expenditure: -41714000.00
CRAV.PA balance_sheet (annual, 2024-12-31) — Capital Stock: 442210000.00
CRAV.PA balance_sheet (quarterly, 2024-12-31) — Capital Stock: 442210000.00
CRAV.PA balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 76864000.00
CRAV.PA balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 76864000.00
CRAV.PA balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 148843000.00
CRAV.PA balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 148843000.00
CRAV.PA balance_sheet (annual, 2024-12-31) — Cash Financial: 57038000.00
CRAV.PA balance_sheet (quarterly, 2024-12-31) — Cash Financial: 57038000.00
CRAV.PA cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -287081000.00
CRAV.PA cash_flow (annual, 2024-12-31) — Change In Working Capital: 164034000.00
CRAV.PA cash_flow (annual, 2024-12-31) — Changes In Cash: 204000000.00
CRAV.PA balance_sheet (annual, 2024-12-31) — Common Stock: 442210000.00
CRAV.PA balance_sheet (quarterly, 2024-12-31) — Common Stock: 442210000.00
CRAV.PA balance_sheet (annual, 2024-12-31) — Common Stock Equity: 3985900000.00
CRAV.PA balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 3985900000.00
CRAV.PA balance_sheet (annual, 2024-12-31) — Defined Pension Benefit: 0.00
CRAV.PA balance_sheet (quarterly, 2024-12-31) — Defined Pension Benefit: 0.00
CRAV.PA cash_flow (annual, 2024-12-31) — Depreciation: 22126000.00
CRAV.PA cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 22126000.00
CRAV.PA income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 22080000.00
CRAV.PA income_statement (annual, 2024-12-31) — Depreciation Income Statement: 22073000.00
CRAV.PA balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 319856000.00
CRAV.PA balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 319856000.00
CRAV.PA income_statement (annual, 2024-12-31) — Diluted Average Shares: 7382465.00
CRAV.PA income_statement (annual, 2024-12-31) — Diluted EPS: 11.59
CRAV.PA income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 85596000.00
CRAV.PA cash_flow (annual, 2024-12-31) — Dividend Received Cfo: 0.00
CRAV.PA cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 0.00